eIFUs and animal tissues in devices: UK seeks feedback on EU rules
This article was originally published in SRA
The UK Medicines and Healthcare products Regulatory Agency is inviting feedback on how it should implement into UK law two EU regulations on: using electronic instructions-for-use (eIFUs) with certain devices, and introducing precautionary measures for devices manufactured using non-viable tissues from Transmissible Spongiform Encephalopathies (TSE)-susceptible species1,2.
You may also be interested in...
The Canadian medtech regulator has recommended updating its list of recognized medical device standards that manufacturers can rely on to demonstrate compliance with local safety, effectiveness and labeling requirements.
Reports from Norway about deaths in very frail, elderly patients soon after receiving Pfizer/BioNTech’s COVID-19 jab have drawn regulatory scrutiny. While the European Medicines Agency has launched an investigation, Australia is examining the need for specific warnings about risks of vaccination in the very frail elderly or terminally ill patients.
The UK’s deployment of COVID-19 vaccines has left vaccine manufacturers worried about emerging discussions on dosing strategies that may not be supported by authorized labeling or published clinical data.